Nicox Ophthalmics
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Nicox Ophthalmics sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Nicox Ophthalmics: 7 sponsored US clinical trials, none currently recruiting.
Nicox Ophthalmics sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 3 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Open Angle Glaucoma, with 1 trials.
Upper-quartile sponsor footprint
Nicox Ophthalmics sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
NCT05938699
Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis
NCT04675242
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT04630808
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT04445519
Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis
NCT03926026
Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT03657797
A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
NCT02756624
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 3 | 3 |
Therapeutic Areas
How the Nicox Ophthalmics archive is shaped
7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).
Phase mix: 3 late (III/IV) vs 4 early (I/II) (balanced across stages).
Top condition: Open Angle Glaucoma (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Nicox Ophthalmics: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Nicox Ophthalmics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Nicox Ophthalmics page
7 registered trials is a research-attention snapshot, not an endorsement of Nicox Ophthalmics or any single study.
- None of Nicox Ophthalmics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Open Angle Glaucoma is the condition Nicox Ophthalmics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Open Angle Glaucoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Nicox Ophthalmics pipeline card: 7 registered trials from official public datasets.Report a data error.